Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes

Withdrawn before enrolling · Phase 3

Conditions studied: Diabetes Mellitus, With Complications

In brief

The purpose of this study is to determine if restoring normal metabolic function in patients with either type I or type II diabetes can improve the impact of the consequences of diabetic complications on heart disease in diabetic patients. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion. A diabetic cardiac disease quality of life questionnaire is completed prior to the start of the treatment and monthly thereafter with detailed analysis performed to measure progress and outcomes. A carotid ultrasound and echocardiogram are performed at baseline and every six months to monitor progress.

Key facts

Study ID
NCT00539435
Run by
Florida Atlantic University
People needed
0
Starts
2007-09-01
Expected to finish
2012-09-01
Last updated by the study team
2016-08-10

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.